Keyword: Acadia Pharmaceuticals

an old man without a smile

8. Nuplazid

Upon its April approval, Acadia’s Nuplazid became the first drug that works by targeting 5-HT2A receptors, providing an advance for Parkinson’s patients who suffer from hallucinations or delusions.